Literature DB >> 12358250

Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms.

John M Hebden1, Elaine Blackshaw, Massimo D'Amato, Alan C Perkins, Robin C Spiller.   

Abstract

OBJECTIVES: Bloating is an important but poorly understood symptom in irritable bowel syndrome (IBS) that is often aggravated by bran. The aim of our study was to determine whether IBS patients with bloating responded to bran differently from healthy controls.
METHODS: A total of 12 patients with IBS (according to Rome I criteria), all with moderate to severe bloating, and 12 healthy controls participated in a two way, double blind, randomized, cross-over trial of bran versus placebo (crushed biscuits) 15 g b.i.d. An average daily pain index and bloating score were derived from daily symptom diaries. On day 14, gastric emptying, small bowel transit, percent remaining in ascending colon, and geometric center of a meal marker at 24 h were calculated from scintigraphic images obtained after ingesting a Tc99m-labeled rice pudding meal with 15 g of either placebo or coarse bran.
RESULTS: Results are given as median (range). Bran significantly increased the pain index and bloating (p < 0.02) in IBS patients but not controls. The most striking finding was that the small bowel transit time of the meal without bran was markedly faster in IBS patients than in controls, being 203 min (range 109-313) versus 367 min (219-543), p < 0.001. Although in controls bran accelerated small bowel transit time to 262 min (180-380), p = 0.03, and significantly reduced % remaining in the ascending colon from 22% (0-46) to 3% (0-25), p = 0.03, this was not seen in the IBS patients. Bran accelerated whole gut transit as assessed by geometric center at 24 h in both IBS patients and controls.
CONCLUSIONS: Bran accelerates small bowel transit and ascending colon clearance without causing symptoms in controls. Small bowel transit is rapid in IBS patients with bloating and, unlike in healthy control subjects, cannot be further accelerated by bran, which nevertheless aggravates symptoms of pain and bloating. We speculate that bran-induced bloating may originate in the colon rather than the small bowel.

Entities:  

Mesh:

Year:  2002        PMID: 12358250     DOI: 10.1111/j.1572-0241.2002.05985.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

1.  The treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Kirsten Weiser; Ryan De Lee
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

2.  Application of dietary fiber in clinical enteral nutrition: a meta-analysis of randomized controlled trials.

Authors:  Gang Yang; Xiao-Ting Wu; Yong Zhou; Ying-Li Wang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

Review 3.  Dietary Carbohydrates and Childhood Functional Abdominal Pain.

Authors:  Bruno P Chumpitazi; Robert J Shulman
Journal:  Ann Nutr Metab       Date:  2016-06-30       Impact factor: 3.374

Review 4.  Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.

Authors:  Michael Camilleri; Lin Chang
Journal:  Gastroenterology       Date:  2008-10-09       Impact factor: 22.682

Review 5.  Management of functional abdominal pain and irritable bowel syndrome in children and adolescents.

Authors:  Eric Chiou; Samuel Nurko
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-06       Impact factor: 3.869

6.  Current gut-directed therapies for irritable bowel syndrome.

Authors:  Howard Y Chang; Eoin C Kelly; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2006-07

Review 7.  Bloating and functional gastro-intestinal disorders: where are we and where are we going?

Authors:  Paola Iovino; Cristina Bucci; Fabrizio Tremolaterra; Antonella Santonicola; Giuseppe Chiarioni
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 8.  [Drug therapy for irritable bowel syndrome. What works, what doesn't work and for whom?].

Authors:  H Mönnikes; M Schmidtmann; I R van der Voort
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

Review 9.  New approaches to the medical treatment of irritable bowel syndrome.

Authors:  Driss Berrada; Katia Canenguez; Tony Lembo
Journal:  Curr Gastroenterol Rep       Date:  2003-08

Review 10.  Functional GI disorders: from animal models to drug development.

Authors:  E A Mayer; S Bradesi; L Chang; B M R Spiegel; J A Bueller; B D Naliboff
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.